References
- 1Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020; 143(10): 3104–20. DOI: 10.1093/brain/awaa240
- 2Neumann B, Schmidbauer ML, Dimitriadis K, Otto S, Knier B, Niesen WD, et al. Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms. J Neurol Sci. 2020; 418: 117090. DOI: 10.1016/j.jns.2020.117090
- 3Lou JJ, Movassaghi M, Gordy D, Olson MG, Zhang T, Khurana MS, et al. Neuropathology of COVID-19 (neuro-COVID): clinicopathological update. Free Neuropathol. 2021; 2.
- 4Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020; 140(1): 1–6. DOI: 10.1007/s00401-020-02166-2
- 5Mukerji SS, Solomon IH. What can we learn from brain autopsies in COVID-19? Neurosci Lett. 2021; 742: 135528. DOI: 10.1016/j.neulet.2020.135528
- 6Sulzer D, Antonini A, Leta V, Nordvig A, Smeyne RJ, Goldman JE, et al. COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside. NPJ Parkinsons Dis. 2020; 6: 18. DOI: 10.1038/s41531-020-00123-0
- 7Badrfam R, Zandifar A. From encephalitis lethargica to COVID-19: Is there another epidemic ahead? Clin Neurol Neurosurg. 2020; 196: 106065. DOI: 10.1016/j.clineuro.2020.106065
- 8Giordano A, Schwarz G, Cacciaguerra L, Esposito F, Filippi M. COVID-19: can we learn from encephalitis lethargica? Lancet Neurol. 2020; 19(7): 570. DOI: 10.1016/S1474-4422(20)30189-7
- 9Brandão PRP, Grippe TC, Pereira DA, Munhoz RP, Cardoso F. New-Onset Movement Disorders Associated with COVID-19. Tremor Other Hyperkinet Mov. 2021; 11: 26. DOI: 10.5334/tohm.595
- 10Geyer HL, Kaufman DM, Parihar RK, Mehler MF. Movement Disorders in COVID-19: Whither Art Thou? Tremor Other Hyperkinet Mov. 2020; 10: 25. DOI: 10.5334/tohm.553
- 11Zheng KS, Dorfman BJ, Christos PJ, Khadem NR, Henchcliffe C, Piboolnurak P, et al. Clinical characteristics of exacerbations in Parkinson disease. Neurologist. 2012; 18(3): 120–4. DOI: 10.1097/NRL.0b013e318251e6f2